2,469
Views
30
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis

, &
Pages 997-1001 | Received 01 Dec 2014, Accepted 08 Jan 2015, Published online: 14 Feb 2015
 

Abstract

The aim of this study was to prepare and characterize spray dried inhalable chitosan nanoparticles (CNPs) for sustained delivery of anti-tubercular drugs, isoniazid (INH) and rifampicin (RIF), to the lungs. CNPs were prepared by ionic gelation technique followed spray drying. Results showed that the CNPs obtained had a smooth spherical shape with an average size of 230 ± 4.5 nm, with a poly dispersity index of 0.180 ± 0.021. Both drugs, were detected in various organs (lungs, liver, spleen and kidney) until 24 h post nebulization. The chemotherapeutic efficacy of a single dose of drug-loaded CNPs suggested that they are more effective against the mycobacterium than free drugs.

Acknowledgements

The author Mr. Tarun Garg is thankful to the Punjab Technical University (PTU), Kapurthala, Punjab, for providing an opportunity to carry out the research work. The author Dr. Amit K. Goyal (under IYBA scheme; BT/01/IYBA/2009 dated 24/05/2010) is thankful to the Department of Biotechnology (DBT), New Delhi, India, for providing financial assistance to carry out research work.

Declaration of interest

The authors report no declarations of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.